Huifang Dong

Statistics

Publications

Citations

942

H-Index

Active since

1999

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

Center for Cancer Research

Altimmune (United States)

Cancer Genetics (United States)

Huifang Dong is an author at Science Applications International Corporation (United States) specializing in inflammation, medicine, and immunopathology.

ORCID

Publications per year

1999–2018

Publications

Thioredoxin, a Redox Enzyme Released in Infection and Inflammation, Is a Unique Chemoattractant for Neutrophils, Monocytes, and T Cells

Riccardo Bertini, O. M. Zack Howard, Huifang Dong et al. · The Journal of Experimental Medicine · 1999 · 339 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15

Ronald Wolf, O. M. Zack Howard, Huifang Dong et al. · The Journal of Immunology · 2008 · 168 citations · Full text

Medicine, Dermatology, Immunology +17

Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry

Michael Pete VanBrunt, Kurt Shanebeck, Zachary Caldwell et al. · Bioconjugate Chemistry · 2015 · 142 citations

Pharmacy, Medicinal Chemistry, Oncology +17

T follicular helper–like cells contribute to skin fibrosis

Devon K. Taylor, Nanette Mittereder, Ellen Kuta et al. · Science Translational Medicine · 2018 · 106 citations

Medicine, Dermatology, Immunology +16

Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.

Xin Chen, John A. Beutler, Thomas G. McCloud et al. · PubMed · 2003 · 86 citations

Medicine, Oncology, Pharmacology +15

1–5 of 8